Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

2.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

3.

Racial differences seen in epigenetic age acceleration in childhood cancer survivors

4.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

5.

For elderly, unfit patients, the all-oral AML regimen shows promise.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot